Work

A multi Organ-on-chip platform for new nanocarriers studies: numerical and experimental studies

Year: 2026
Type: other
Abstract: It is widely accepted that organ-on-chip systems will have a significant impact on the future of the pharmaceutical and biotechnology industry through the discovery of new drugs using robust in vitro platforms that will complement or potentially replace the current pre-clinical animal studies [1–5]. In this work, it is proposed an innovative and robust microfluidic multi-OoC platform, to support the 3D biological models, comprising a network of microchannels for cell medium delivery, nutrient supply, and drug infusion, 4 organoid chambers and biosensing reservoirs for biomarkers capture. The proposed integrated approach combines detailed numerical simulations of fluid dynamics and molecular transport with rigorous experimental validation by high-speed particle tracking flow visualizations. Several studies were performed to study and optimize the device: i) numerical simulations to optimize device geometry, mixing elements (e.g. groves, pillars), and mass/heat transport; ii) PDMS surface modification to reduce adsorption and improve device performance; iii) device microfabrication by 3D-printing and PDMS replica molding; and iv) experimental high speed flow visualization. The results show that PDMS wettability can be improved for over 7-months using bulk modifications (Brij L4 or PEO) [6,7], which reduces molecular adsorption (decreasing albumin adsorption) [8], and enhances fluid dynamics (reduce walls drag forces by promoting smoother and efficient and uniform fluid transport) [9]. Numerical simulations indicate that properly designed mixing elements substantially improve mass transport and distribution (nutrients and temperature) across the device [9]. Experimental validation of the multi organ on chip platform confirms its robustness and simplicity for supporting controlled perfusion and reproducible biological assays. Further experimental assays of biomarkers capture and quantification in the biosensing reservoirs will be performed. It is anticipated that the proposed integrated technology combined with 3D biological models will potentially enhance their performance in new drug screening. The proposed multi organ on chip platform will advance the microsystem prototype toward a robust animal replacement tool by providing ultra sensitive, real time in situ monitoring to assess and predict the safety and efficacy of novel nanocarriers, thereby accelerating nanomedicine discovery and clinical translation.
Language: English
Open Access status: green
OpenAlex ID: W7159748819
Cites:
Cited by:
Related to: 10